Diabetes Archives -

Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics another way to

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval

https://pharmaphorum.com/news/lillys-new-drug-mounjaro-tirzepatide-wins-us-fda-approval/

News/ News/ R&D

Novo Nordisk once-weekly insulin clears first phase 3 test

Phil Taylor Diabetes, drug delivery, insulin, insulin icodec, metabolic disease, Novo Nordisk 0 Comment

For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact

Novo Nordisk once-weekly insulin clears first phase 3 test

https://pharmaphorum.com/news/novo-nordisk-once-weekly-insulin-clears-first-phase-3-test/

Digital/ News/ News

Abbott joins alliance to bring ‘artificial pancreas’ system to Europe

Phil Taylor Abbott, artificial pancreas, CamDiab, Diabetes, digital, digital health, Ypsomed 0 Comment

Abbott has joined forces with two other companies to bring an automated insulin delivery (AID) system to people

Abbott joins alliance to bring ‘artificial pancreas’ system to Europe

https://pharmaphorum.com/news/abbott-joins-alliance-to-bring-artificial-pancreas-system-to-europe/

Market Access/ Views and analysis

Why the drug pricing debate is focused on insulin

Ben Hargreaves Diabetes, Drug pricing, insulin, pharma, PhRMA 0 Comment

The treatment has been around for over a century but insulin has still become the centre of the

Why the drug pricing debate is focused on insulin

https://pharmaphorum.com/views-and-analysis/why-the-drug-pricing-debate-is-focused-on-insulin/

News/ News/ Patients

NICE expands access to real-time glucose monitoring for diabetics

Phil Taylor continuous glucose monitoring, Diabetes, NHS, NICE 0 Comment

More than 250,000 people living with type 1 diabetes in the UK will be offered real-time continuous glucose

NICE expands access to real-time glucose monitoring for diabetics

https://pharmaphorum.com/news/nice-expands-access-to-real-time-glucose-monitoring-for-diabetics/

News/ News/ Sales and Marketing

Insulin price caps on the horizon as Senate leader plans vote

Phil Taylor Diabetes, Drug pricing, insulin, legislation, US 0 Comment

The US Senate will vote in the coming weeks on whether to introduce a $35 cap on the

Insulin price caps on the horizon as Senate leader plans vote

https://pharmaphorum.com/news/insulin-price-caps-on-the-horizon-as-senate-leader-plans-vote/

News/ News/ Patients

Does COVID-19 infection raise the risk of diabetes?

Phil Taylor coronavirus, COVID-19, Diabetes, patients 0 Comment

Researchers in Germany are have found a possible link between mild COVID-19 infection and an increased risk of

Does COVID-19 infection raise the risk of diabetes?

https://pharmaphorum.com/news/does-covid-19-infection-raise-the-risk-of-diabetes/

~ai-9d6a62d3-dfc0-4e08-82a5-ed2a25f94450_

Digital/ News/ News

Real-time Abbott glucose monitor available to NHS after UK launch

Phil Taylor Abbott, continuous glucose monitoring, Diabetes, digital, digital health, FreeStyle Libre, NHS, wearable 0 Comment

The latest version of Abbott’s FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible

Real-time Abbott glucose monitor available to NHS after UK launch

https://pharmaphorum.com/news/real-time-abbott-glucose-monitor-available-to-nhs-after-uk-launch/

Ardelyx’s-ambition-to-revolutionise-kidney-treatment

Market Access/ News/ News

EU clears Bayer’s chronic kidney disease drug Kerendia

Phil Taylor Bayer, chronic kidney disease, Diabetes, EU, finerenone, Kerendia, regulatory approval 0 Comment

Bayer has claimed EU approval for Kerendia, its new drug for chronic kidney disease (CKD) in people with

EU clears Bayer’s chronic kidney disease drug Kerendia

https://pharmaphorum.com/news/eu-clears-bayers-chronic-kidney-disease-drug-kerendia/

Trending

Diabetes

Login